Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice
Joyonna Gamble‐George, Jordan R. Conger, Nolan D. Hartley, et al.
Psychopharmacology (2013) Vol. 228, Iss. 3, pp. 401-409
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Neurobiological Interactions Between Stress and the Endocannabinoid System
Maria Morena, Sachin Patel, Jaideep S. Bains, et al.
Neuropsychopharmacology (2015) Vol. 41, Iss. 1, pp. 80-102
Open Access | Times Cited: 557
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder
Matthew N. Hill, Patrizia Campolongo, Rachel Yehuda, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 80-102
Open Access | Times Cited: 202
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar, Mauro Maccarrone, Mario van der Stelt
Progress in Lipid Research (2018) Vol. 71, pp. 1-17
Open Access | Times Cited: 189
Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation
Brian C. Shonesy, Rebecca J. Bluett, Teniel S Ramikie, et al.
Cell Reports (2014) Vol. 9, Iss. 5, pp. 1644-1653
Open Access | Times Cited: 142
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
Rebecca J. Bluett, Joyonna Gamble‐George, Daniel J. Hermanson, et al.
Translational Psychiatry (2014) Vol. 4, Iss. 7, pp. e408-e408
Open Access | Times Cited: 137
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure
Rebecca J. Bluett, Rita Báldi, Andre Haymer, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 120
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, et al.
Neuropharmacology (2021) Vol. 195, pp. 108626-108626
Closed Access | Times Cited: 57
Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses
Matthew N. Hill, Sachin Patel
Biology of Mood & Anxiety Disorders (2013) Vol. 3, Iss. 1, pp. 19-19
Open Access | Times Cited: 101
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking
Katherine M. Holleran, Hadley H. Wilson, Tracy L. Fetterly, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 8, pp. 2062-2071
Open Access | Times Cited: 83
Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence
Samuel W. Centanni, Bridget Morris, Joseph R. Luchsinger, et al.
Neuropsychopharmacology (2018) Vol. 44, Iss. 3, pp. 526-537
Open Access | Times Cited: 81
The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System
Anthony L. Berger, Angela M. Henricks, Janelle M. Lugo, et al.
Biological Psychiatry (2018) Vol. 84, Iss. 8, pp. 611-623
Open Access | Times Cited: 63
Delineation of an insula-BNST circuit engaged by struggling behavior that regulates avoidance in mice
Joseph R. Luchsinger, Tracy L. Fetterly, Kellie M. Williford, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Endocannabinoids and Mental Disorders
Tiziana Rubino, Erica Zamberletti, Daniela Parolaro
Handbook of experimental pharmacology (2015), pp. 261-283
Closed Access | Times Cited: 63
Cannabinoid Modulation of the Stressed Hippocampus
Franciele Franco Scarante, Carla Vila-Verde, Vinícius Detoni Lopes, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 56
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Joyonna Gamble‐George, Rita Báldi, Lindsay R. Halladay, et al.
eLife (2016) Vol. 5
Open Access | Times Cited: 50
Role of endocannabinoid signaling in a septohabenular pathway in the regulation of anxiety- and depressive-like behavior
Casey R. Vickstrom, Xiaojie Liu, Shuai Liu, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3178-3191
Open Access | Times Cited: 43
Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence
Jill Turner, Rubik Ray, Brian Lee, et al.
Molecular Psychiatry (2013) Vol. 19, Iss. 7, pp. 801-810
Open Access | Times Cited: 44
Anxiety associated with palatable food withdrawal is reversed by the selective FAAH inhibitor PF‐3845: A regional analysis of the contribution of endocannabinoid signaling machinery
Marialuisa de Ceglia, Maria Vittoria Micioni Di Bonaventura, Adele Romano, et al.
International Journal of Eating Disorders (2023) Vol. 56, Iss. 6, pp. 1098-1113
Open Access | Times Cited: 9
Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Jill Turner, Derek S. Wilkinson, Rachel L. Poole, et al.
Neuropsychopharmacology (2013) Vol. 38, Iss. 10, pp. 2035-2047
Open Access | Times Cited: 29
Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice
Yvonne Bouter, Magdalena M. Brzózka, Rafał Ryguła, et al.
Cannabis and Cannabinoid Research (2019) Vol. 5, Iss. 1, pp. 51-61
Open Access | Times Cited: 17
Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches
Veronika Kondev, Nathan D. Winters, Sachin Patel
International review of neurobiology (2021), pp. 143-193
Closed Access | Times Cited: 12
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes
Shira Hirsch, Liad Hinden, Meital Ben-David Naim, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 254-269
Open Access | Times Cited: 8
Evidence for functional interaction between the CB1 and the mGlu7 receptors mediated signaling in modulation of anxiety behavior and cognition.
Barbara Chruścicka‐Smaga, Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, et al.
Life Sciences (2024) Vol. 361, pp. 123313-123313
Closed Access | Times Cited: 1
Animal Models of Risk Factors for Suicidal Ideation and Behaviour
Sarah A. Stuart, Paul Butler, Emma Robinson
Springer eBooks (2014), pp. 295-314
Closed Access | Times Cited: 7
Endocannabinoid signaling as an intrinsic component of the circuits mediating adaptive responses to repeated stress exposure in adult male sprague dawley rats
Ryan J. Newsom, Jacob Stafford, Robert J. Garcia, et al.
Stress (2019) Vol. 23, Iss. 2, pp. 174-189
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top